Can one therapy session beat ten? new study tests quick fix for anxiety and depression
NCT ID NCT07363915
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested two ways to help adults with mild anxiety and depression in primary care. One was a 10-week group program, the other a single 50-minute session. Researchers wanted to see if the shorter option worked just as well. 136 people took part, and their symptoms were tracked for a year.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Psychological interventions (group therapy and single-session therapy)
- What this could lead to
- If successful, this could show that a single therapy session is as effective as a longer group program for mild anxiety and depression, potentially saving time and resources.
- What could go wrong
- This is a small, completed trial in Spain, so results may not apply to other populations. The interventions are behavioral, so individual results can vary widely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
136 people
The number who actually took part.
- Started
-
Feb 2021
- Finished
-
Sep 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Adults aged 18-65 years. 2\. Referred from primary care by a general practitioner. 3\. Mild to moderate anxious-depressive symptoms based on the GP's clinical judgement during routine consultations, with or without psychotropic medication. Exclusion Criteria: 1. Meeting DSM-IV Axis I diagnostic criteria based on the Structured Clinical Interview (SCID-I), assessed by two clinical resident psychologists. 2\. Receiving active mental health treatment (public or private). 3\. Current substance dependence (except nicotine). 4\. Organic, neurological, or cognitive disorder related to the symptoms. 5\. Language barriers that precluded participation or completion of assessments.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anxiety are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Universitario Príncipe de Asturias (recruitment from 4 primary care centres), Spain
Alcalá de Henares, Madrid, 28806, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a phone app that blocks distracting apps ease depression?
- Can video games calm anxious teens?
- Can a group program teach teens to cope before therapy starts?
- Could a Patient's playlist take the sting out of nerve testing?
- Three spanish group sessions put a neuroscience twist on anxiety therapy
- Can a rewired EMDR therapy ease the mental toll of migration?